Hansen Medical (NASDAQ:
HNSN)
-32% premarket after warning Q2 revenue will come in at $3.1-3.3M vs. expectations of $8.8M, saying "general macroeconomic conditions" impacted customers' capital spending. Hansen also withdrew guidance for system placements for the year. (
PR)